Profil
Michael A.
Yamin served as the Director & Vice President at Angion Biomedica Corp.
from 2013 to 2020.
Prior to that, he obtained a doctorate degree from The Rockefeller University.
Anciens postes connus de Michael A. Yamin
Sociétés | Poste | Fin |
---|---|---|
ANGN BIOM | Directeur/Membre du Conseil | 04/06/2020 |
Formation de Michael A. Yamin
The Rockefeller University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |